1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Infecciosas

Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Fortún J, Martín-Dávila P, Gómez-Mampaso E, González-García A, Barbolla I, Gómez-García I, Wikman P, Ortíz J, Navas E, Cuartero C, Gijón D, Moreno S.

    Extra-pulmonary tuberculosis: differential aspects and role of 16S-rRNA in urine

    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE . 18(4): 478-485. Nº de citas: 14

    [doi:10.5588/ijtld.13.0555]

  • van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J.

    Leishmaniasis in immunosuppressed individuals

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases . 20(4): 286-299. Nº de citas: 189

    [doi:10.1111/1469-0691.12556]

  • Sainz T, Diaz L, Navarro ML, Rojo P, Blázquez D, Ramos JT, de José MI, Álvarez-Fuente M, Serrano-Villar S, Mellado MJ, Muñoz-Fernández MA.

    Cardiovascular biomarkers in vertically HIV-infected children without metabolic abnormalities

    Atherosclerosis . 233(2): 410-414. Nº de citas: 16

    [doi:10.1016/j.atherosclerosis.2014.01.025]

  • Gutiérrez F, García L, Padilla S, Alvarez D, Moreno S, Navarro G, Gómez-Sirvent J, Vidal F, Asensi V, Masiá M.

    Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs

    HIV MEDICINE . 15(4): 213-223. Nº de citas: 21

    [doi:10.1111/hiv.12104]

  • Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ, D:A:D study Group.

    Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D: A: D study

    BMC NEPHROLOGY . 15: 51-51. Nº de citas: 7

    [doi:10.1186/1471-2369-15-51]

  • Monge S, Guillot V, Alvarez M, Chueca N, Stella N, Peña A, Delgado R, Córdoba J, Aguilera A, Vidal C, García F.

    Clinically Relevant Transmitted Drug Resistance to First Line Antiretroviral Drugs and Implications for Recommendations

    Plos One . 9(3): . Nº de citas: 12

    [doi:10.1371/journal.pone.0090710]

  • Abad-Fernández M, Cabrera C, García E, Vallejo A.

    Transient increment of HTLV-2 proviral load in HIV-1-co-infected patients during treatment intensification with raltegravir

    JOURNAL OF CLINICAL VIROLOGY . 59(3): 204-207. Nº de citas: 2

    [doi:10.1016/j.jcv.2013.12.010]

  • Balandin Moreno B, Fernández Simón I, Pintado García V, Sánchez Romero I, Isidoro Fernández B, Romera Ortega MA, Alcántara Carmona S, Pérez Redondo M, Galdos Anuncibay P.

    Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients

    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES . 46(3): 175-180. Nº de citas: 32

    [doi:10.3109/00365548.2013.861608]

  • González-Castillo J, Martín-Sánchez FJ, Llinares P, Menéndez R, Mujal A, Navas E, Barberán J.

    Guidelines for the management of community-acquired pneumonia in the elderly patient

    REVISTA ESPANOLA DE QUIMIOTERAPIA . 27(1): 69-86. Nº de citas: 29

  • Patier de la Peña JL, González-García A, Prieto Pareja E, Norman FF, Rojas Marcos J, Benito Paniagua D.

    Parsonage-Turner syndrome during the treatment of HIV/HHV8-related multicentric Castleman disease.

    Revista clinica espanola . 214(2): .

    [doi:10.1016/j.rce.2013.11.009]

  • Ehehalt U, Schunk M, Jensenius M, van Genderen PJ, Gkrania-Klotsas E, Chappuis F, Schlagenhauf P, Castelli F, Lopez-Velez R, Parola P, Burchard GD, Cramer JP.

    Leishmaniasis acquired by travellers to endemic regions in Europe: A EuroTravNet multi-centre study

    TRAVEL MEDICINE AND INFECTIOUS DISEASE . 12(2): 167-172. Nº de citas: 33

    [doi:10.1016/j.tmaid.2013.12.003]

  • Martinez-Perez A, Norman FF, Monge-Maillo B, Perez-Molina JA, Lopez-Velez R.

    An approach to the management of Trypanosoma cruzi infection ( Chagas' disease) in immunocompromised patients

    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY . 12(3): 357-373. Nº de citas: 14

    [doi:10.1586/14787210.2014.880652]

  • Casado JL, Bañon S, Andrés R, Perez-Elías MJ, Moreno A, Moreno S.

    Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients

    OSTEOPOROSIS INTERNATIONAL . 25(3): 1071-1079. Nº de citas: 28

    [doi:10.1007/s00198-013-2506-3]

  • Grint D.

    Increased incidence of antiretroviral drug discontinuation among patients with viremic hepatitis C virus coinfection and high hyaluronic acid, a marker of liver fibrosis

    AIDS . 28(4): 577-587. Nº de citas: 10

    [doi:10.1097/QAD.0000000000000069]

  • Simmons R, Semenenko I, Tolpina M, Tereschenko R, Kotlik L, Zasyptka L, Murphy G, McKinney E, Copas A, Malyuta R, Porter K.

    High Percentage of Recent HIV Infection Leading to Onward Transmission in Odessa, Ukraine Associated with Young Adults

    AIDS AND BEHAVIOR . 18(2): 411-418. Nº de citas: 2

    [doi:10.1007/s10461-013-0518-9]

  • Sanz-Canalejas L, Gómez-Mampaso E, Cantón-Moreno R, Varona-Crespo C, Fortún J, Dronda F.

    Peliosis hepatis due to disseminated tuberculosis in a patient with AIDS

    Infection . 42(1): 185-189. Nº de citas: 11

    [doi:10.1007/s15010-013-0490-3]

  • Pérez-Molina JA.

    Management of Trypanosoma cruzi coinfection in HIV-positive individuals outside endemic areas

    CURRENT OPINION IN INFECTIOUS DISEASES . 27(1): 9-15. Nº de citas: 14

    [doi:10.1097/QCO.0000000000000023]

  • Casado JL, Marín A, Moreno A, Iglesias V, Perez-Elías MJ, Moreno S, Corral I.

    Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

    JOURNAL OF NEUROVIROLOGY . 20(1): 54-61. Nº de citas: 9

    [doi:10.1007/s13365-013-0228-0]